share_log

Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $130

Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $130

信托证券重申买入Tenet Healthcare,将目标股价上调至130美元
Benzinga ·  05/01 08:57

Truist Securities analyst David Macdonald reiterates Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $120 to $130.

Truist Securities分析师戴维·麦克唐纳重申了Tenet Healthcare(纽约证券交易所代码:THC)的买入并将目标股价从120美元上调至130美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发